Several obesity- and nutrient-related gene polymorphisms but not FTO and UCP variants modulate postabsorptive resting energy expenditure and fat-induced thermogenesis in obese individuals: The NUGENOB Study

International Journal of Obesity

Volumn 33, Issue 6, 2009, Pages 669-679

  Goossens, G H ^a,l   Petersen, L ^b   Blaak, E E ^a   Hul, G ^a   Arner, P ^c   Astrup, A ^d   Froguel, P ^e   Patel, K ^f   Pedersen, O ^g   Polak, J ^h   Oppert, J M ⁱ   Martinez, J A ^j   Sorensen T I A ^k   Saris, W H M ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e INSTITUT PASTEUR DE LILLE   (France)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g STENO DIABETES CENTER   (Denmark)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ SORBONNE UNIVERSITÉ   (France)

^j UNIVERSITY OF NAVARRA   (Spain)

^k The Capital Region   (Denmark)

^l MAASTRICHT UNIVERSITY   (Netherlands)

more..

Author keywords

Genetic polymorphisms; Phenotype; Postprandial; Resting energy expenditure

Indexed keywords

ADULT; ARTICLE; CART GENE; ENERGY EXPENDITURE; EUROPE; FEMALE; FTO GENE; GAD2 GENE; GENE; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HSD11B1 GENE; HUMAN; LIPC GENE; MAJOR CLINICAL STUDY; MALE; NUTRIENT; OBESITY; PCSK1 GENE; PHENOTYPE; PPARG3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THERMOGENESIS; UCP GENE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; ENERGY METABOLISM; FEMALE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HUMANS; ION CHANNELS; LIPASE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; PROTEINS; REST; THERMOGENESIS; YOUNG ADULT;

EID: 67449141659     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.59     Document Type: Article

References (41)

1. Bogardus C, Lillioja S, Ravussin E, Abbott W, Zawadzki JK, Young A et al. Familial dependence of the resting metabolic rate. N Engl J Med 1986; 315: 96-100.
2. Astrup A, Buemann B, Christensen NJ, Madsen J, Gluud C, Bennett P et al. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992; 74: 279-286.
3. Blaak EE, Hul G, Verdich C, Stich V, Martinez JA, Petersen M et al. Impaired fat-induced thermogenesis in obese subjects: the NUGENOB study. Obesity (Silver Spring) 2007; 15: 653-663.
4. Fontaine E, Savard R, Tremblay A, Despres JP, Poehlman E, Bouchard C. Resting metabolic rate in monozygotic and dizygotic twins. Acta Genet Med Gemellol (Roma) 1985; 34: 41-47.
5. Clement K, Sørensen TIA (eds). Obesity: Genomics and Postgenomics 1st edn. Informa Healthcare, UK, 2007. pp 1-600.
6. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894.
7. Major GC, Doucet E, Trayhum P, Astrup A, Tremblay A. Clinical significance of adaptive thermogenesis. Int J Obes (Lond) 2007; 31: 204-212.
8. Petersen M, Taylor MA, Saris WH, Verdich C, Toubro S, Macdonald I et al. Randomized, multi-center trial of two hypoenergetic diets in obese subjects: high- versus low-fat content. Int J Obes (Lond) 2006; 30: 552-560.
9. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982; 36: 936-942.
10. Tehard B, Saris WH, Astrup A, Martinez JA, Taylor MA, Barbe P et al. Comparison of two physical activity questionnaires in obese subjects: the NUGENOB study. Med Sci Sports Exerc 2005; 37: 1535-1541.
11. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. / Physiol 1949; 109: 1-9.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
13. Sørensen TIA, Boutin P, Taylor MA, Larsen LH, Verdich C, Petersen L et al. Genetic polymorphisms and weight loss in obesity: a randomised trial of hypo-energetic high- versus low-fat diets. PLoS Clin Trials 2006; 1: e12.
14. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005; 6: 221-234.
15. Blomeke B, Shields PG. Laboratory methods for the determination of genetic polymorphisms in humans. IARC Sci Publ 1999; 133-147.
16. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Heredity 1995; 86: 248-249.
17. Zhao JH, Lissarrague S, Essioux L, Sham PC. GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics 2002; 18: 1694-1695.
18. Boesgaard TW, Castella SI, Andersen G, Albrechtsen A, Sparso T, Borch-Johnsen K et al. A -243A->G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population-based sample of 5857 middle-aged White subjects. Diabet Med 2007; 24: 702-706.
19. Boutin P, Dina C, Vasseur F, Dubois S, Corset L, Seron K et al. GAD2 on chromosome 10p12 is a candidate gene for human obesity. PLoS Biol 2003; 1: E68.
20. Guerardel A, Barat-Houari M, Vasseur F, Dina C, Vatin V, Clement K et al. Analysis of sequence variability in the CART gene in relation to obesity in a Caucasian population. BMC Genet 2005; 6: 19.
21. Swarbrick MM, Waldenmaier B, Pennacchio LA, Lind DL, Cavazos MM, Geller F et al. Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol 2005; 3: e315.
22. Vrang N, Tang-Christensen M, Larsen PJ, Kristensen P. Recombinant CART peptide induces c-Fos expression in central areas involved in control of feeding behaviour. Brain Res 1999; 818: 499-509.
23. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS et al. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998; 393: 72-76.
24. Van Vugt DA, Lujan ME, Froats M, Krzemien A, Couceyro PR, Reid RL. Effect of fasting on cocaine-amphetamine-regulated transcript, neuropeptide Y, and leptin receptor expression in the non-human primate hypothalamus. Neuroendocrinology 2006; 84: 83-93.
25. Draper N, Echwald SM, Lavery GG, Walker EA, Fraser R, Davies E et al. Association studies between microsatellite markers within the gene encoding human llbeta-hydroxysteroid dehydrogenase type 1 and body mass index, waist to hip ratio, and glucocorticoid metabolism. J Clin Endocrinol Metab 2002; 87: 4984-4990.
26. Rosado EL, Bressan J, Martins MF, Cecon PR, Martinez JA. Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite 2007; 49: 635-643.
27. Landsberg L. Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A 1990; 12: 817-830.
28. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001; 10: 1491-1501.
29. Gu D, O'Dell SD, Chen XH, Miller GJ, Day IN. Evidence of multiple causal sites affecting weight in the IGF2-INS-TH region of human chromosome 11. Hum Genet 2002; 110: 173-181.
30. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V, Hewitson KS et al. The obesity-associated FTO gene encodes a 2-oxoglutaratedependent nucleic acid demethylase. Science 2007; 318: 1469-1472.
31. Berentzen T, Kring SI, Holst C, Zimmermann E, Jess T, Hansen T et al. Lack of association of fatness-related FTO gene variants with energy expenditure or physical activity. / Clin Endocrinol Metab 2008; 93: 2904-2908.
32. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323.
33. Lyssenko V, Lupi R, Marchetti P, Del Guerra S, Orho-Melander M, Almgren P et al. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007; 117: 2155-2163.
34. Maestrini S, Podesta F, Di Blasio AM, Savia G, Brunani A, Tagliaferri A et al. Lack of association between UCP2 gene polymorphisms and obesity phenotype in Italian Caucasians. J Endocrinol Invest 2003; 26: 985-990.
35. Yanovski JA, Diament AL, Sovik KN, Nguyen TT, Li H, Sebring NG et al. Associations between uncoupling protein 2, body composition, and resting energy expenditure in lean and obese African American, white, and Asian children. Am J Clin Nutr 2000; 71: 1405-1420.
36. Fang QC, Jia WP, Yang M, Bao YQ Chen L, Zhang R et al. Effect of polymorphism of uncoupling protein 3 gene -55 (C>T) on the resting energy expenditure, total body fat and regional body fat in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2005; 22: 485-488.
37. Halsall DJ, Luan J, Saker P, Huxtable, S Farooqi IS, Keogh J et al. Uncoupling protein 3 genetic variants in human obesity: the c55t promoter polymorphism is negatively correlated with body mass index in a UK Caucasian population. Int J Obes Relat Metab Disord 2001; 25: 472-477.
38. Lanouette CM, Giacobino JP, Perusse L, Lacaille M, Yvon C, Chagnon M et al. Association between uncoupling protein 3 gene and obesity-related phenotypes in the Quebec Family Study. Mol Med 2001; 7: 433-441.
39. Schrauwen P, Hoeks J, Schaart G, Kornips E, Binas B, Van De Vusse GJ et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J 2003; 17: 2272-2274.
40. Cancello R, Tounian A, Poitou C, Clement K. Adiposity signals, genetic and body weight regulation in humans. Diabetes Metab 2004; 30: 215-227.
41. Goyenechea E, Dolores Parra M, Martinez JA. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator-activated-receptorgamma2 gene polymorphisms. Br J Nutr 2006; 96: 965-972.